Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma.

Leukemia & lymphoma - 1 Dec 2014

Favaloro James, Liyadipitiya Tulita, Brown Ross, Yang Shihong, Suen Hayley, Woodland Narelle, Nassif Najah, Hart Derek, Fromm Phillip, Weatherburn Claire, Gibson John, Ho P Joy, Joshua Douglas

Abstract excerpt

Myeloid derived suppressor cells (MDSCs) are a heterogeneous population of cells that have been implicated as inhibitors of lymphopoiesis in patients with malignancies. They have a consensus phenotype of CD33+/CD11b+/HLA-DRlo/- and can be further divided into CD15 + granulocytic (G-MDSC) and CD14 + monocytic (M-MDSC) subsets. We characterized MDSCs in patients with multiple myeloma (MM) and found a significant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Surface
Share to Cell Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Granulocyte Colony-Stimulating Factor

Share to Immunomodulation

Share to Immunophenotyping

Share to Multiple Myeloma

Share to Myeloid Cells

Share to T-Lymphocytes, Regulatory

Source

Identifiers

PMID: 24625328
DOI: 10.3109/10428194.2014.904511

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma.PMID 24625328Read ↗

Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDSSemantic proximity Read ↗

Functional Role of Granulocytic Myeloid-Derived Suppressor Cells in CAR-T Therapy: Insights from Single- Cell RNA Sequencing in Multiple MyelomaSemantic proximity Read ↗

Decreased circulating myeloid-derived suppressor cell count at the engraftment is one of the risk factors for multiple myeloma relapse after autologous hematopoietic stem cell transplantationSemantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Detection of myeloid-derived suppressor cells by flow cytometry.Semantic proximity Read ↗

On the origin of myeloid-derived suppressor cells.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells.Semantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases.Semantic proximity Read ↗

Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.